Início/Ações/OCUL

OCUL

USD

Ocular Therapeutix Inc. Common Stock

$10.900-0.300 (-2.679%)

Preço em tempo real

Healthcare

Biotecnologia

Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado

Fundamentos da empresa

Estatísticas de negociação

Métricas de mercado

Abertura

$11.200

Máximo

$11.355

Mínimo

$10.400

Volume

1.84M

Fundamentos da empresa

Capitalização de mercado

2.3B

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

2.72M

Bolsa de valores

NGM

Moeda

USD

Faixa de 52 semanas

Mínimo $5.785Atual $10.900Máximo $13.85

Notícias relacionadas

4/11/2025 · 12:05

GlobeNewswire

Ocular Therapeutix™ Reports Third Quarter 2025 Financial Results and Business Highlights

Recent Investor Day highlighted how AXPAXLI™ is positioned to redefine retina based on potential superiority label, market expansion, and immediate adoptability Announced today that SOL-R achieved target

Ver mais

Ocular Therapeutix™ Reports Third Quarter 2025 Financial Results and Business Highlights

30/10/2025 · 20:14

Analyst Upgrades

TD Cowen Maintains Buy on Ocular Therapeutix, Raises Price Target to $20

TD Cowen analyst Tara Bancroft maintains Ocular Therapeutix with a Buy and raises the price target from $14 to $20.

Ver mais

TD Cowen Maintains Buy on Ocular Therapeutix, Raises Price Target to $20

28/10/2025 · 11:00

GlobeNewswire

Ocular Therapeutix™ to Report Third Quarter 2025 Financial Results on November 4, 2025

BEDFORD, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular")), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it plans

Ver mais